Healthcare professional and a patient standing in a hospital exam room setting while looking at a clipboard

Cardiac diagnostics and monitoring

Conditions

Patient selection for long-term cardiac monitoring

Indications, Safety, and WarningsThe material on this website should not be considered the exclusive source of information, it does not replace or supersede information contained in the device manual(s).Please note that the intended use of a product may vary depending on geographical approvals.See the device manual(s) for detailed information regarding the intended use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events.For a MRI compatible device(s), consult the MRI information in the device manual(s) before performing a MRI.If a device is eligible for eIFU usage, instructions for use can be found at Medtronic’s website manuals.medtronic.com.Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.Medtronic products placed on European markets bear the CE mark and the UKCA mark (if applicable). For any further information, contact your local Medtronic representative.Medtronic medical devices marketed in Spain are in compliance with the Spanish legislation in force.

Learn more about challenging conditions.

Get more details about the conditions that may require long-term cardiac monitoring with the LINQ™ family of insertable cardiac monitors (ICMs).

Unexplained syncope

Stroke

Atrial fibrillation (AF)

Continuous monitoring with the LINQ™ family of ICMs

The LINQ™ family of ICMs (Reveal LINQ™ ICM and LINQ II™ ICM) works continuously to capture comprehensive and actionable data over a longer period of time than short-term monitors to deliver superior yield that can increase the rate of diagnosis for patients with AF, cryptogenic stroke, and syncope.

Discover LINQ™ ICMs

Is 30 days long enough?

Here’s what you may be missing with a conventional 30-day external monitor:

88% of AF diagnoses in cryptogenic stroke patients^†,1
87% of AF diagnoses in large and small vessel stroke patients²

Find a diagnosis, faster.^‡,3–7

When answers are hard to find, the LINQ™ family of ICMs helps eliminate patient compliance issues,^8–10 provides clinicians with trusted data for treatment planning, and gives patients reassurance that their heart will be continuously monitored.

See the data (open in new window)

Related products

† Based on Kaplan-Meier estimates.

‡ Compared to standard of care.

Sanna T, Diener H, Passman RS, et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370(26):2478–2486. doi: 10.1056/NEJMoa1313600.
Bernstein RA, Kamel H, Granger CB, et al. Atrial fibrillation in patients with stroke attributed to large- or small-vessel disease: 3-year results from the STROKE AF Randomized Clinical Trial. JAMA Neurol. 2023;80(12):1277–1283. doi: 10.1001/jamaneurol.2023.3931.
Nasir JM, Pomeroy W, Marler A, et al. Predicting determinants of atrial fibrillation or flutter for therapy elucidation in patients at risk for thromboembolic events (PREDATE AF) study. Heart Rhythm. 2017;14(7):955–961. doi: 10.1016/j.hrthm.2017.04.026.
Reiﬀel JA, Verma A, Kowey PR, et al. Incidence of previously undiagnosed atrial fibrillation using insertable cardiac monitors in a high-risk population: The REVEAL AF Study. JAMA Cardiol. 2017;2(10):1120–1127. doi: 10.1001/jamacardio.2017.3180.
Healey JS, Alings M, Ha A, et al. Subclinical atrial fibrillation in older patients. Circulation. 2017;136(14):1276–1283. doi: 10.1001/jamacardio.2017.3180. doi: 10.1161/CIRCULATIONAHA.117.028845.
Philippsen TJ, Christensen LS, Hansen MG, Dahl JS, Brandes A. Detection of subclinical atrial fibrillation in high-risk patients using an insertable cardiac monitor. JACC Clin Electrophysiol. 2017;3(13):1557–1564. doi: 10.1016/j.jacep.2017.06.020.
Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. Eur Heart J. 2018;39(21):1883–1948. doi: 10.1093/eurheartj/ehy037.
Vasamreddy CF, Dalal D, Dong J, et al. Symptomatic and asymptomatic atrial fibrillation in patients undergoing radiofrequency catheter ablation. J Cardiovasc Electrophysiol. 2006;17(2):134–139. doi: 10.1111/j.1540-8167.2006.00359.x.
Kamel H, Navi BB, Elijovich L, et al. Pilot randomized trial of outpatient cardiac monitoring after cryptogenic stroke. Stroke. 2013;44:528–530. doi.org/10.1161/STROKEAHA.112.679100.
Stahrenberg, Weber-Krüger M, Seegers J, et al. Enhanced detection of paroxysmal atrial fibrillation by early and prolonged continuous holter monitoring in patients with cerebral ischemia presenting in sinus rhythm. Stroke. 2010;41(12):2884–2888. doi: 10.1161/STROKEAHA.110.591958.

You are leaving the Medtronic Europe site

You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.

We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.

It is possible that some of the products on the other site are not approved in your region or country.

First Name

Last Name

Title

STATE / PROVINCE

EMAIL

PHONE

Hospital Or Practice

Job Role

Specialty

About the latest products, technologies and services:

Yes No

About educational and clinical information (e.g., Medtronic Academy):

Yes No

Would you like to receive the Medtronic customer experience survey?

Yes No

Your information will be processed and protected in accordance with our privacy statement.

Selecting “no” to marketing emails above will not affect your other email selections, and a Medtronic representative will still reach out via email, if selected. Your personal data will used to manage your relationship with Medtronic, and, if you consent, to provide you with relevant email updates based on your user preferences. You can opt-out of receiving such emails at any time by clicking the unsubscribe link in the relevant email. Medtronic may use pixels and other technologies in emails to gather statistics around email opening and clicks, to help us improve our communications and to provide you with relevant content.

For more information, see the {link}

You can always change your preferences or update your personal details by visiting the Preference center. {link}

First Name

Last Name

Title

STATE / PROVINCE

EMAIL

PHONE

Hospital Or Practice

Job Role

Specialty

About the latest products, technologies and services:

Yes No

About educational and clinical information (e.g., Medtronic Academy):

Yes No

Would you like to receive the Medtronic customer experience survey?

Yes No

Your information will be processed and protected in accordance with our privacy statement.

Selecting “no” to marketing emails above will not affect your other email selections, and a Medtronic representative will still reach out via email, if selected. Your personal data will used to manage your relationship with Medtronic, and, if you consent, to provide you with relevant email updates based on your user preferences. You can opt-out of receiving such emails at any time by clicking the unsubscribe link in the relevant email. Medtronic may use pixels and other technologies in emails to gather statistics around email opening and clicks, to help us improve our communications and to provide you with relevant content.

For more information, see the {link}

You can always change your preferences or update your personal details by visiting the Preference center. {link}